- In March 2024, BD (Becton, Dickinson and Company) launched its next-generation BD Vacutainer UltraTouch Blood Collection Set, designed to improve the blood draw experience with enhanced needle technology that minimizes patient discomfort and improves first-stick success rates. This innovation reflects BD’s continued investment in user-centric design and addresses the growing demand for safe, efficient, and patient-friendly blood collection systems across clinical settings
- In February 2024, Roche Diagnostics introduced a fully integrated sample collection and transport solution for its cobas diagnostic systems, enhancing pre-analytical workflow efficiency and reducing contamination risks. This development strengthens Roche’s position as a leader in diagnostic precision and reliability, while supporting large-scale testing operations through seamless integration with laboratory infrastructure
- In January 2024, Thermo Fisher Scientific Inc. partnered with health departments across Southeast Asia to supply advanced sample collection kits for infectious disease surveillance and pandemic preparedness. These kits include viral transport media, swabs, and safety packaging designed to maintain specimen integrity in diverse environmental conditions, reflecting Thermo Fisher’s role in supporting global health resilience through robust diagnostic logistics
- In December 2023, Copan Diagnostics Inc. expanded its product line with the launch of the eNAT 2.0, an upgraded nucleic acid transport system that enables simultaneous sample stabilization and inactivation of pathogens. This system is tailored for molecular testing workflows and is particularly suited for remote and point-of-care collection, supporting the shift toward decentralized diagnostics and enhancing biosafety
- In November 2023, Qiagen unveiled its QIAreach Sample Prep System, a compact, automated device designed to standardize and streamline sample preparation processes in low-resource and decentralized testing environments. The device supports multiple sample types, including blood and swabs, aligning with the global trend toward point-of-care diagnostics and expanding access to accurate testing in underserved regions
